Eledon Pharmaceuticals, Inc. (ELDN)
USD 4.18
(-7.11%)
USD 4.18
(-7.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 120 Thousand | - | - |
| Cost of Revenue | 374 Thousand | 373 Thousand | 195 Thousand | 183 Thousand | 182 Thousand | 11 Thousand |
| Gross Profit | -374 Thousand | -373 Thousand | -195 Thousand | -63 Thousand | -182 Thousand | -11 Thousand |
| Operating Expenses | 43 Million | 39.78 Million | 36.86 Million | 16.18 Million | 14.18 Million | 14.06 Million |
| Selling, General and Administrative Expenses | 12.68 Million | 12.7 Million | 13.13 Million | 10.05 Million | 6.05 Million | 7.24 Million |
| Research and Development Expenses | 30.31 Million | 27.08 Million | 23.73 Million | 6.13 Million | 8.12 Million | 6.81 Million |
| Other Expenses | - | 462 Thousand | 7000.00 | 79 Thousand | 40 Thousand | -5000.00 |
| Cost and Expenses | 43 Million | 39.78 Million | 36.86 Million | 16.18 Million | 14.18 Million | 14.06 Million |
| Operating Income | -43 Million | 8.49 Million | -36.86 Million | -18.46 Million | -16.05 Million | -14.06 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -462 Thousand | -2.35 Million | -404 Thousand | 1.86 Million | -5000.00 |
| Earnings before Tax | -40.32 Million | -87.96 Million | -36.86 Million | -23.21 Million | -16.01 Million | -14.06 Million |
| Net Income | -40.32 Million | -87.5 Million | -34.5 Million | -22.81 Million | -17.87 Million | -14.06 Million |
| Earnings Per Share Basic | -0.00 | -6.13 | -2.33 | -15.72 | -27.27 | -28.11 |
| Earnings Per Share Diluted | -1.64 | -6.13 | -2.33 | -15.72 | -27.27 | -28.11 |
| Weighted Average Shares Outstanding | 24.61 Billion | 14.28 Million | 14.81 Million | 1.45 Million | 655.52 Thousand | 500.29 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 24.61 Million | 14.28 Million | 14.81 Million | 1.45 Million | 655.52 Thousand | 500.3 Thousand |
| Gross Margin | - | - | - | -0.52 | - | - |
| EBIT Margin | - | - | - | -114.32 | - | - |
| Profit Margin | - | - | - | -190.09 | - | - |
| EBITDA | - | -87.59 Million | -36.66 Million | -23.03 Million | -15.82 Million | -14.04 Million |
| Earnings Before Tax Margin | - | - | - | -153.88 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 560 Thousand | - | - | - |
| Cost of Revenue | 97 Thousand | 95 Thousand | 94 Thousand | 374 Thousand | 94 Thousand | 94 Thousand |
| Gross Profit | -97 Thousand | -95 Thousand | 466 Thousand | -374 Thousand | -94 Thousand | -94 Thousand |
| Operating Expenses | 14.4 Million | 10.77 Million | 10.24 Million | 42.62 Million | 11.19 Million | 10.35 Million |
| Selling, General and Administrative Expenses | 4.29 Million | 3.36 Million | 3.17 Million | - | 3.26 Million | 3.15 Million |
| Research and Development Expenses | 10.1 Million | 7.41 Million | 7.06 Million | - | 7.93 Million | 7.2 Million |
| Other Expenses | 869 Thousand | 574 Thousand | 712 Thousand | - | 849 Thousand | 775 Thousand |
| Cost and Expenses | 14.5 Million | 10.86 Million | 10.33 Million | 43 Million | 11.19 Million | 10.35 Million |
| Operating Income | -14.5 Million | -10.86 Million | -10.33 Million | -43 Million | -11.19 Million | -10.35 Million |
| Interest Expense | - | - | 338 Thousand | - | - | - |
| Income Tax Expense | - | 51.72 Thousand | 50.18 Thousand | - | 133.58 Thousand | -28.08 Thousand |
| Earnings before Tax | -44.9 Million | -10.29 Million | -9.62 Million | -116.53 Million | -10.34 Million | -9.57 Million |
| Net Income | -44.9 Million | -10.29 Million | -9.62 Million | -116.53 Million | -10.34 Million | -9.57 Million |
| Earnings Per Share Basic | -1.06 | -0.34 | -0.40 | - | -0.35 | -0.40 |
| Earnings Per Share Diluted | -1.06 | -0.34 | -0.40 | - | -0.35 | -0.40 |
| Weighted Average Shares Outstanding | 42.27 Million | 29.98 Million | 24.21 Million | 24.61 Million | 29.97 Million | 24 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.27 Million | 29.98 Million | 24.21 Million | 24.61 Million | 29.97 Million | 24 Million |
| Gross Margin | - | - | 0.83 | - | - | - |
| EBIT Margin | - | - | -18.29 | - | - | - |
| Profit Margin | - | - | -17.19 | - | - | - |
| EBITDA | -14.4 Million | -10.77 Million | -10.24 Million | - | -11.1 Million | -10.26 Million |
| Earnings Before Tax Margin | - | - | -18.46 | - | - | - |
EASTW-R
PKST
CXC
ACUS
MDP
BIOS